title: Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway.
abstract: Ginsenoside Rh1 has been reported to possess antiallergic and anti-inflammatory activities, but its effects on monocytes remain to be determined. Herein, we investigated the effects of Rh1 on the expression of MCP-1 and CCR2, activation of MAPK signaling, and chemotaxis of monocytes. Treatment of Rh1 decreased the levels of MCP-1 and CCR2 and the expression of VLA5 and activated β1 integrin on the cell surface, and attenuated the phosphorylation of MAPKs. Based on these results, the inhibitory effects of Rh1 on monocyte function should be regarded as a promising new anti-inflammatory response with a potential therapeutic role against inflammation-dependent diseases.
authors: Department of Biotechnology, Bioenergy Research Center, Chonnam National University, Gwangju 500-757, South Korea.
authors: Yeo-Jin
authors: YJ
authors: Choi
authors: Ji-Hae
authors: JH
authors: Yoon
authors: Seon-Woo
authors: SW
authors: Cha
authors: Seong-Gene
authors: SG
authors: Lee